{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:22:47Z","timestamp":1783488167107,"version":"3.55.0"},"reference-count":121,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda y Nutrici\u00f3n"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.endonu.2015.02.006","type":"journal-article","created":{"date-parts":[[2015,4,7]],"date-time":"2015-04-07T17:57:18Z","timestamp":1428429438000},"page":"e57-e72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Gu\u00eda cl\u00ednica para el manejo de pacientes con carcinoma diferenciado de tiroides de bajo riesgo"],"prefix":"10.1016","volume":"62","author":[{"given":"Juan Jos\u00e9","family":"D\u00edez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Oleaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"\u00c1lvarez-Escol\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1s","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Galofr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.endonu.2015.02.006_bib0610","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/ijc.27711","article-title":"Estimates of global cancer prevalence for 27 sites in the adult population in 2008","volume":"132","author":"Bray","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.endonu.2015.02.006_bib0615","unstructured":"European Network of Cancer Registries, International Agency for Research on Cancer [consultado: 1 Ago 2014]. Disponible en: http:\/\/eco.iarc.fr\/eucan\/Cancer.aspx?Cancer=35"},{"key":"10.1016\/j.endonu.2015.02.006_bib0620","unstructured":"Surveillance, Epidemiology, and End Results Program 2011 SEER*Stat Database: SEER 9 Registry Research Data (1973-2008) National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch [consultado: 1 Ago 2014]. Disponible en: www.seer.cancer.gov."},{"key":"10.1016\/j.endonu.2015.02.006_bib0625","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1089\/thy.2008.0281","article-title":"Thyroid cancer incidence and survival in the national cancer institute surveillance, epidemiology, and end results race\/ethnicity groups","volume":"20","author":"Yu","year":"2010","journal-title":"Thyroid"},{"key":"10.1016\/j.endonu.2015.02.006_bib0630","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/thy.2008.0210","article-title":"Time trends for thyroid cancer in northwestern Spain: True rise in the incidence of micro and larger forms of papillary thyroid carcinoma","volume":"19","author":"Rego-Iraeta","year":"2009","journal-title":"Thyroid"},{"issue":"Spp 3","key":"10.1016\/j.endonu.2015.02.006_bib0635","doi-asserted-by":"crossref","first-page":"iii30","DOI":"10.1093\/annonc\/mdq090","article-title":"Cancer incidence and mortality in Spain: Estimates and projections for the period 1981-2012","volume":"21","author":"S\u00e1nchez","year":"2010","journal-title":"An Oncol"},{"key":"10.1016\/j.endonu.2015.02.006_bib0640","unstructured":"Galceran J, Ameijide A, Larra\u00f1aga N, Alem\u00e1n A, Torrella A, Chico M, et al. Estimates of cancer incidence in Spain, 2014 [consultado: 1 Nov 2014]. Disponible en: www.redecan.es."},{"key":"10.1016\/j.endonu.2015.02.006_bib0645","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1089\/thy.2013.0257","article-title":"The epidemic of thyroid cancer in the United States: The role of endocrinologists and ultrasounds","volume":"24","author":"Udelsman","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/j.endonu.2015.02.006_bib0650","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1089\/thy.2010.0137","article-title":"The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years","volume":"21","author":"Hughes","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/j.endonu.2015.02.006_bib0655","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1089\/thy.2012.0392","article-title":"Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: Review of incidence trends by socioeconomic status within the surveillance, epidemiology, and end results registry, 1980-2008","volume":"23","author":"Li","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/j.endonu.2015.02.006_bib0660","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1001\/jama.295.18.2164","article-title":"Increasing incidence of thyroid cancer in the United States, 1973-2002","volume":"295","author":"Davies","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.endonu.2015.02.006_bib0665","doi-asserted-by":"crossref","first-page":"75","DOI":"10.7762\/cnr.2014.3.2.75","article-title":"Dietary factors and the risk of thyroid cancer: A review","volume":"3","author":"Choi","year":"2014","journal-title":"Clin Nutr Res"},{"key":"10.1016\/j.endonu.2015.02.006_bib0670","doi-asserted-by":"crossref","first-page":"T235","DOI":"10.1530\/ERC-14-0131","article-title":"The influence of the environment on the development of thyroid tumors: A new appraisal","volume":"21","author":"Marcello","year":"2014","journal-title":"Endocr Rel Cancer"},{"key":"10.1016\/j.endonu.2015.02.006_bib0675","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1530\/EJE-13-0065","article-title":"Obesity is a risk factor for thyroid cancer in a large, ultrasonographically screened population","volume":"168","author":"Han","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endonu.2015.02.006_bib0680","doi-asserted-by":"crossref","unstructured":"La Vecchia C, Malvezzi M, Bosetti C, Garavello W, Bertuccio P, Levi F, et al. Thyroid cancer mortality and incidence: A global overview. Int J Cancer. 2014 Oct 4. doi: 10.1002\/ijc.29251.","DOI":"10.1002\/ijc.29251"},{"key":"10.1016\/j.endonu.2015.02.006_bib0685","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jamaoto.2014.1","article-title":"Current thyroid cancer trends in the United States","volume":"140","author":"Davies","year":"2014","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.endonu.2015.02.006_bib0690","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1530\/eje.1.02158","article-title":"European Thyroid Cancer Taskforce. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium","volume":"154","author":"Pacini","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endonu.2015.02.006_bib0695","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/thy.2009.0110","article-title":"Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer","volume":"19","author":"Cooper","year":"2009","journal-title":"Thyroid"},{"issue":"Suppl 1","key":"10.1016\/j.endonu.2015.02.006_bib0700","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cen.12515","article-title":"Guidelines for the management of thyroid cancer","volume":"81","author":"Perros","year":"2014","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.endonu.2015.02.006_bib0705","series-title":"American Joint Committee on Cancer. Cancer Staging Manual","year":"2010"},{"key":"10.1016\/j.endonu.2015.02.006_bib0710","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1530\/eje.1.02014","article-title":"Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: A consensus report","volume":"153","author":"Pacini","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endonu.2015.02.006_bib0715","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1089\/thy.2010.0178","volume":"20","author":"Tuttle","year":"2010","journal-title":"Thyroid"},{"key":"10.1016\/j.endonu.2015.02.006_bib0720","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1530\/EJE-11-0466","article-title":"Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid c\u00e1ncer patients","volume":"165","author":"Castagna","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endonu.2015.02.006_bib0725","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0140-6736(12)62205-3","article-title":"Controversies in primary treatment of low-risk papillary thyroid cancer","volume":"381","author":"McLeod","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.endonu.2015.02.006_bib0730","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1210\/jc.2012-2458","article-title":"Life expectancy is reduced in differentiated thyroid cancer patients \u2265 45 years old with extensive local tumour invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patients","volume":"98","author":"Verburg","year":"2013","journal-title":"J Clin Endocrinol Metabolism"},{"key":"10.1016\/j.endonu.2015.02.006_bib0735","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ecl.2014.02.010","article-title":"Update on differentiated thyroid cancer staging","volume":"43","author":"Momesso","year":"2014","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.endonu.2015.02.006_bib0740","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s12020-014-0213-2","article-title":"Optimal management of a biochemical incomplete response to therapy in differentiated thyroid cancer: Aggressive treatment or cautious observation","volume":"46","author":"Tuttle","year":"2014","journal-title":"Endocrine"},{"key":"10.1016\/j.endonu.2015.02.006_bib0745","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1089\/thy.2011.0232","article-title":"In differentiated thyroid cancer, an incomplete structural response to therapy is associated with significant worse clinical outcome than only an incomplete thyroglobulin response","volume":"21","author":"Vaisman","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/j.endonu.2015.02.006_bib0750","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-2265.2012.04342.x","article-title":"Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapy","volume":"77","author":"Vaisman","year":"2012","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.endonu.2015.02.006_bib0755","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s12020-013-9935-9","article-title":"Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation","volume":"44","author":"Gallicchio","year":"2013","journal-title":"Endocrine"},{"key":"10.1016\/j.endonu.2015.02.006_bib0760","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1089\/thy.2008.0270","article-title":"Prognostic factors affecting neck lymph node recurrence and distant met\u00e1stasis in papillary microcarcinoma of the thyroid: Results of a study in 445 patients","volume":"19","author":"Mercante","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.endonu.2015.02.006_bib0765","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1530\/EJE-12-0105","article-title":"Scoring system for predicting recurrences in patients with papillary thyroid microcarcinoma","volume":"167","author":"Buffet","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endonu.2015.02.006_bib0770","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1210\/jc.2012-3728","article-title":"Papillary thyroid microcarcinomas: A comparative study of the characteristics and risk factors at presentation in 2 cancer registries","volume":"98","author":"Malandrino","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.02.006_bib0775","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4158\/EP.13.5.498","article-title":"Management of low-risk differentiated thyroid cancer","volume":"13","author":"Mazzaferri","year":"2007","journal-title":"Endocr Pract"},{"key":"10.1016\/j.endonu.2015.02.006_bib0780","first-page":"269","article-title":"Cancer recurrente in papillary thyroid microcarcinoma: A multivariate analysis on 231 patients with a 12-year follow-up","volume":"37","author":"Pedrazzini","year":"2012","journal-title":"Minerva Endocrinol"},{"key":"10.1016\/j.endonu.2015.02.006_bib0785","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/1471-2407-8-296","article-title":"Prognostic parameters for recurrence of papillary thyroid microcarcinoma","volume":"8","author":"Kim","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.endonu.2015.02.006_bib0790","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1210\/jc.2011-1546","article-title":"Risk factors for neck lymph node metastasis in papillary thyroid microcarcinoma: A study of 1066 patients","volume":"97","author":"Zhang","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.02.006_bib0795","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s00268-010-0886-5","article-title":"Analysis of the clinicopathologic features of papillary thyroid microcarcinoma based on 7-mm tumor size","volume":"35","author":"Lee","year":"2011","journal-title":"World J Surg"},{"key":"10.1016\/j.endonu.2015.02.006_bib0800","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/jama.2013.3190","article-title":"Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer","volume":"309","author":"Xing","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.endonu.2015.02.006_bib0805","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1210\/jc.2012-1775","article-title":"The BRAF V600E mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: Single institution results from a large cohort study","volume":"97","author":"Elisei","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.02.006_bib0810","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0140-6736(13)60109-9","article-title":"Progress in molecular-based management of differentiated thyroid cancer","volume":"381","author":"Xing","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.endonu.2015.02.006_bib0815","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1210\/jc.2011-3135","article-title":"Clinical implications of highly sensitive detection of the BRAF V600E mutation in fine needle aspirations of thyroid nodules: A comparative analysis of 3 molecular assays in 4585 consecutive cases in a BRAF V600E mutation prevalent area","volume":"97","author":"Lee","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.02.006_bib0820","doi-asserted-by":"crossref","first-page":"E934","DOI":"10.1210\/jc.2012-3930","article-title":"Allele percentage of the BRAF V600E mutation in papillary thyroid carcinoma and corresponding lymph node metastases: No evidence for a role in tumor progression","volume":"98","author":"Gandolfi","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.02.006_bib0825","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1002\/cncr.26425","article-title":"A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma","volume":"118","author":"Niemeier","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.endonu.2015.02.006_bib0830","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1200\/JCO.2014.55.5094","article-title":"BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence","volume":"32","author":"Xing","year":"2014","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.endonu.2015.02.006_bib0835","doi-asserted-by":"crossref","first-page":"E754","DOI":"10.1210\/jc.2013-3734","article-title":"TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas","volume":"99","author":"Melo","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.02.006_bib0840","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1007\/s00268-009-0359-x","article-title":"Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: Our treatment strategies and outcomes","volume":"34","author":"Sugitani","year":"2010","journal-title":"World J Surg"},{"key":"10.1016\/j.endonu.2015.02.006_bib0845","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00268-009-0303-0","article-title":"An observation trial for papillary thyroid microcarcinoma in Japanese patients","volume":"34","author":"Ito","year":"2010","journal-title":"World J Surg"},{"key":"10.1016\/j.endonu.2015.02.006_bib0850","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1210\/jc.2011-1740","article-title":"Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC)","volume":"96","author":"Spencer","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.02.006_bib0855","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1530\/EJE-07-0896","article-title":"Thyroid papillary microcarcinoma: A descriptive and meta-analysis study","volume":"159","author":"Roti","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endonu.2015.02.006_bib0860","unstructured":"National Comprehensive Cancer Network guidelines [consultado 31 DIc 2014]. Disponible en: http:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp"},{"key":"10.1016\/j.endonu.2015.02.006_bib0865","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1210\/jc.2012-3682","article-title":"Low- or high-dose radioiodine remnant ablation for differentiated thyroid carcinoma: A meta-analysis","volume":"98","author":"Cheng","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.02.006_bib0870","unstructured":"Pacini F. Nuevos enfoques en el tratamiento con radioyodo en el c\u00e1ncer diferenciado de tiroides. Simposio: Tratamiento del c\u00e1ncer de tiroides. 55 Congreso de la Sociedad Espa\u00f1ola de Endocrinolog\u00eda y Nutrici\u00f3n. Granada, 17 de mayo de 2013."},{"key":"10.1016\/j.endonu.2015.02.006_bib0875","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.oraloncology.2013.03.444","article-title":"Selective use of RAI for ablation and adjuvant therapy after total thyroidectomy for differentiated thyroid cancer: A practical approach to clinical decision making","volume":"49","author":"Tuttle","year":"2013","journal-title":"Oral Oncol"},{"key":"10.1016\/j.endonu.2015.02.006_bib0880","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00268-013-2335-8","article-title":"Association between serum thyrotropin concentration and growth of asymptomatic papillary thyroid microcarcinoma","volume":"38","author":"Sugitani","year":"2014","journal-title":"World J Surg"},{"key":"10.1016\/j.endonu.2015.02.006_bib0885","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/CCO.0000000000000143","article-title":"Nonoperative management of low-risk differentiated thyroid carcinoma","volume":"27","author":"Ito","year":"2015","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.endonu.2015.02.006_bib0890","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/BF02303583","article-title":"Low-risk differentiated thyroid cancer: The need for selective treatment","volume":"4","author":"Shaha","year":"1997","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.endonu.2015.02.006_bib0895","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0039-6060(98)70035-2","article-title":"Unilateral total lobectomy: Is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma?","volume":"124","author":"Hay","year":"1998","journal-title":"Surgery."},{"key":"10.1016\/j.endonu.2015.02.006_bib0900","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1210\/jc.2014-3039","article-title":"Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years","volume":"100","author":"Adam","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.02.006_bib0905","unstructured":"Sobrinho Simoes M, Asa SL, Kroll TG, Nikiforov Y, DeLellis R, Farid P, et al. Follicular Carcinoma. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C, editors. World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of Endocrine Organs. Lyon: IARC Press; 2004. p. 67-72."},{"key":"10.1016\/j.endonu.2015.02.006_bib0910","first-page":"2946","article-title":"Morbidity and mortality in folicular thyroid cancer","volume":"80","author":"De Groot","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.02.006_bib0915","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/0002-9343(94)90321-2","article-title":"Long term impact of initial surgical and medical therapy on papillary and folicular thyroid cancer","volume":"97","author":"Mazzaferri","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.endonu.2015.02.006_bib1215","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1385\/EP:17:2:109","article-title":"Diagnostic criteria in well-differentiated thyroid carcinomas","volume":"17","author":"Fonseca","year":"2006","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.endonu.2015.02.006_bib0925","first-page":"1130","article-title":"Follicular thyroid carcinoma with capsular invasion alone: A nonthreatening malignancy","volume":"112","author":"Van Heerden","year":"1992","journal-title":"Surgery"},{"key":"10.1016\/j.endonu.2015.02.006_bib0930","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/cncr.20081","article-title":"Follicular thyroid carcinoma: Histology and prognosis","volume":"100","author":"D\u2019Avanzo","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.endonu.2015.02.006_bib0935","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/modpathol.2010.133","article-title":"Follicular thyroid carcinoma","volume":"24","author":"Sobrinho-Simoes","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.endonu.2015.02.006_bib0940","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00428-006-0162-0","article-title":"How to define follicular thyroid carcinoma","volume":"448","author":"Schmid","year":"2006","journal-title":"Virchows Arch"},{"key":"10.1016\/j.endonu.2015.02.006_bib0945","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.suronc.2009.06.006","article-title":"Diagnostic and therapeutic strategies for minimally and widely invasive follicular thyroid carcinoma","volume":"20","author":"Huang","year":"2011","journal-title":"Surg Oncol"},{"key":"10.1016\/j.endonu.2015.02.006_bib0950","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/01.sla.0000186421.30982.d2","article-title":"Follicular thyroid carcinoma. The role of histology stagins systems in predicting survival","volume":"242","author":"Lo","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.endonu.2015.02.006_bib0955","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1089\/thy.2012.0051","article-title":"Outcomes and prognostic factors of 251 patients with minimally invasive follicular thyroid carcinoma","volume":"22","author":"Sugino","year":"2012","journal-title":"Thyroid"},{"issue":"Suppl 6","key":"10.1016\/j.endonu.2015.02.006_bib0960","first-page":"10","article-title":"Primary surgery for differentiated thyroid cancer in the new millennium","volume":"35","author":"Dralle","year":"2012","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.endonu.2015.02.006_bib0965","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1245\/s10434-012-2697-4","article-title":"Can minimally invasive folicular thyroid cancer be approached as a benign lesion","volume":"20","author":"Goffredo","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.endonu.2015.02.006_bib0970","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1507\/endocrj.EJ12-0419","article-title":"Prognostic factors of minimally invasive folicular thyroid carcinoma: Extensive vascular invasion significantly affects patient prognosis","volume":"60","author":"Ito","year":"2013","journal-title":"Endocr J"},{"key":"10.1016\/j.endonu.2015.02.006_bib0975","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/SLA.0b013e3181a77b7b","article-title":"Follicular thyroid carcinoma in an iodine-replete endemic goiter region","volume":"249","author":"Asari","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.endonu.2015.02.006_bib0980","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00423-013-1140-z","article-title":"Minimally invasive follicular thyroid cancer (MIFTC)-a consensus report of the European Society of Endocrine Surgeons (ESES)","volume":"399","author":"Dionigi","year":"2014","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.endonu.2015.02.006_bib0985","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1089\/thy.2010.0353","article-title":"Prognosis and prognostic factors for distant metastases and tumor mortality in follicular thyroid carcinoma","volume":"21","author":"Sugino","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/j.endonu.2015.02.006_bib0990","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1046\/j.1445-2197.2002.02556.x","article-title":"Minimally invasive follicular thyroid carcinoma: Completion of thyroidectomy or not","volume":"72","author":"Dellbridge","year":"2002","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.endonu.2015.02.006_bib0995","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1002\/hed.23511","article-title":"Association of vascular invasion with increased mortality in patients with minimally invasive follicular thyroid carcinoma but not with widely invasive thyroid carcinoma","volume":"36","author":"Kim","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.endonu.2015.02.006_bib1000","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1245\/s10434-014-3734-2","article-title":"Does completion thyroidectomy improve the outcome of patients with minimally invasive follicular carcinoma of the thyroid?","volume":"21","author":"Sugino","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.endonu.2015.02.006_bib1005","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1056\/NEJMoa1109589","article-title":"Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer","volume":"366","author":"Mallick","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.endonu.2015.02.006_bib1010","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1108586","article-title":"Strategies of radioiodine ablation in patients with low-risk thyroid cancer","volume":"366","author":"Schlumberger","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.endonu.2015.02.006_bib1015","doi-asserted-by":"crossref","first-page":"R473","DOI":"10.1530\/ERC-14-0286","article-title":"Current controversies in the initial post-surgical radioactive iodine therapy for thyroid cancer: A narrative review","volume":"21","author":"Blumhardt","year":"2014","journal-title":"Endocr Rel Cancer"},{"key":"10.1016\/j.endonu.2015.02.006_bib1020","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ecl.2014.02.012","article-title":"Thyrotropin in the development and management of thyroid cancer","volume":"43","author":"McLeod","year":"2014","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.endonu.2015.02.006_bib1025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2265.2010.03898.x","article-title":"Does an undetectable rhTSH-stimulated Tg level 12 months after initial treatment of thyroid cancer indicate remission?","volume":"74","author":"Klubo-Gwiezdzinska","year":"2011","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.endonu.2015.02.006_bib1030","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1530\/EJE-14-0148","article-title":"Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: A clinical position paper","volume":"171","author":"Giovanela","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endonu.2015.02.006_bib1035","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1210\/jc.2002-021702","article-title":"A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma","volume":"88","author":"Mazzaferri","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.02.006_bib1040","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000354537","article-title":"2013 European Thyroid Association Guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer","volume":"2","author":"Leenhardt","year":"2013","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.endonu.2015.02.006_bib1045","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/cncr.27770","article-title":"H\u00fcrthle cell carcinoma: A population-level analysis of 3311 patients","volume":"119","author":"Goffredo","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.endonu.2015.02.006_bib1220","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1089\/thy.2006.16.1151","article-title":"Trend in thyroid carcinoma size, age at diagnosis and histology in a retrospective study of 500 cases diagnosed over 20 years","volume":"16","author":"Trimboli","year":"2006","journal-title":"Thyroid"},{"key":"10.1016\/j.endonu.2015.02.006_bib1055","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/archsurg.141.5.489","article-title":"Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer","volume":"141","author":"Stulak","year":"2006","journal-title":"Arch Surg."},{"key":"10.1016\/j.endonu.2015.02.006_bib1060","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1210\/jc.2014-1681","article-title":"Preoperative neck ultrasound in clinical node-negative differentiated thyroid cancer","volume":"99","author":"Wang","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.02.006_bib1065","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/cncr.26500","article-title":"The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: A meta-analysis","volume":"118","author":"Kim","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.endonu.2015.02.006_bib1070","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/MD.0b013e31826a9c71","article-title":"BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: A systematic review and meta-analysis","volume":"91","author":"Tufano","year":"2012","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.endonu.2015.02.006_bib1075","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.biopha.2014.03.008","article-title":"The role of BRAF (V600E) mutation as poor prognostic factor for the outcome of patients with intrathyroid papillary thyroid carcinoma","volume":"68","author":"Pelizzo","year":"2014","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.endonu.2015.02.006_bib1080","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1245\/s10434-010-1137-6","article-title":"Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: A meta-analysis","volume":"17","author":"Zetoune","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.endonu.2015.02.006_bib1085","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1089\/thy.2011.0317","article-title":"American Thyroid Association design and feasibility of a prospective randomized controlled trial of prophylactic central lymph node dissection for papillary thyroid carcinoma","volume":"22","author":"Carling","year":"2012","journal-title":"Thyroid"},{"key":"10.1016\/j.endonu.2015.02.006_bib1090","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/jjco\/hyt087","article-title":"Systematic evaluation of prophylactic neck dissection for the treatment of papillary thyroid carcinoma","volume":"43","author":"Zhu","year":"2013","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.endonu.2015.02.006_bib1095","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00268-001-0176-3","article-title":"Pattern of nodal metastasis for primary and reoperative thyroid cancer","volume":"26","author":"Machens","year":"2002","journal-title":"World J Surg"},{"key":"10.1016\/j.endonu.2015.02.006_bib1100","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.SLA.0000055273.58908.19","article-title":"Lymph node metastasis from 259 papillary thyroid microcarcinomas: Frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection","volume":"237","author":"Wada","year":"2003","journal-title":"Ann Surg"},{"key":"10.1016\/j.endonu.2015.02.006_bib1105","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.surg.2010.09.019","article-title":"Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer","volume":"148","author":"Hughes","year":"2010","journal-title":"Surgery"},{"key":"10.1016\/j.endonu.2015.02.006_bib1110","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1089\/thy.2012.0043","article-title":"The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension","volume":"22","author":"Randolph","year":"2012","journal-title":"Thyroid"},{"key":"10.1016\/j.endonu.2015.02.006_bib1115","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.surg.2014.02.010","article-title":"Impact of prophylactic central compartment neck dissection on locorregional recurrence of differentiated thyroid cancer in clinically node-negative patients: A retrospective study of a large clinical series","volume":"155","author":"Conzo","year":"2014","journal-title":"Surgery"},{"key":"10.1016\/j.endonu.2015.02.006_bib1120","doi-asserted-by":"crossref","first-page":"385787","DOI":"10.1155\/2014\/385787","article-title":"Clinical characteristics related to central lymph node metastasis in cN0 papillary thyroid carcinoma: A retrospective study of 916 patients","volume":"2014","author":"Jiang","year":"2014","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.endonu.2015.02.006_bib1125","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1001\/archoto.2010.112","article-title":"Central nodal metastases in papillary thyroid carcinoma based on tumor histologic type and focality","volume":"136","author":"Salter","year":"2010","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.endonu.2015.02.006_bib1130","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1530\/EJE-12-0744","article-title":"The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma","volume":"168","author":"Jeon","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endonu.2015.02.006_bib1135","first-page":"510","article-title":"Correlation analysis on central lymph node met\u00e1stasis in 276 patients with cN0 papillary thyroid carcinoma","volume":"6","author":"Wang","year":"2013","journal-title":"Int J Clin Exp Pathol."},{"key":"10.1016\/j.endonu.2015.02.006_bib1140","doi-asserted-by":"crossref","first-page":"807","DOI":"10.12659\/MSM.890182","article-title":"Risk factors of dentral lymph node met\u00e1stasis in cN0 papillary thyroid carcinoma: A study of 529 patients","volume":"20","author":"Liang","year":"2014","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.endonu.2015.02.006_bib1145","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00000658-199809000-00005","article-title":"The importance of surgeon experience for clinical and economic outcomes from thyroidectomy","volume":"228","author":"Sosa","year":"1998","journal-title":"Ann Surg"},{"key":"10.1016\/j.endonu.2015.02.006_bib1150","first-page":"667","article-title":"Morbidity following thyroid surgery: Does surgeon volume matter?","volume":"393","author":"Gonz\u00e1lez-S\u00e1nchez","year":"2013","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.endonu.2015.02.006_bib1155","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1210\/jc.2012-1123","article-title":"Long-term surveillance of papillary thyroid cancer patients who do not undergo postoperative radioiodine remnant ablation: Is there a role for serum thyroglobulin measurement?","volume":"97","author":"Durante","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.02.006_bib1160","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1210\/jc.2010-2695","article-title":"Risk-adapted management of differentiated thyroid cancer assessed by a sensitive measurement of basal serum thyroglobulin","volume":"96","author":"Malandrino","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.02.006_bib1165","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/hed.21214","article-title":"Postsurgery serum thyroglobulin disappearance kinetic in patients with differentiated thyroid carcinoma","volume":"32","author":"Giovanella","year":"2010","journal-title":"Head Neck"},{"key":"10.1016\/j.endonu.2015.02.006_bib1225","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF03349472","article-title":"Serum thyroglobulin in patients undergoing subtotal thyroidectomy for toxic and nontoxic goiter","volume":"5","author":"Feldt-Rasmussen","year":"1982","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.endonu.2015.02.006_bib1175","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1089\/thy.2010.0355","article-title":"Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy","volume":"21","author":"Miyauchi","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/j.endonu.2015.02.006_bib1180","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1210\/jc.2013-3156","article-title":"Unstimulated highly sensitive thyroglobulin in follow-up of differentiated thyroid cancer patients: A meta-analysis","volume":"99","author":"Giovanela","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.02.006_bib1185","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1210\/jc.2003-031521","article-title":"Follow-up of low risk patients with papillary thyroid cancer: Role of neck ultrasound in detecting lymph node metastases","volume":"89","author":"Torlontano","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.02.006_bib1190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1530\/eje.0.1480019","article-title":"Serum thyroglobulin and 131I whole body scan after recombinant human TSH stimulation in the follow-up of low-risk patients with differentiated thyroid cancer","volume":"148","author":"Torlontano","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endonu.2015.02.006_bib1195","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1530\/EJE-13-0386","article-title":"Ultrasensitive serum thyroglobulin measurement is useful for the follow-up of patients treated with total thyroidectomy without radioactive iodine ablation","volume":"169","author":"Nascimento","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endonu.2015.02.006_bib1200","doi-asserted-by":"crossref","first-page":"R141","DOI":"10.1530\/ERC-13-0066","article-title":"Differentiated thyroid carcinoma: Defining new paradigms for postoperative management","volume":"20","author":"Durante","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.endonu.2015.02.006_bib1205","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-139-5_Part_1-200309020-00010","article-title":"Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens","volume":"139","author":"Chiovato","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.endonu.2015.02.006_bib1210","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1210\/jcem.85.1.6310","article-title":"Is diagnostic iodine-131 scanning useful alter total thyroid ablation for differentiated thyroid carcinoma","volume":"85","author":"Cailleux","year":"2000","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Endocrinolog\u00eda y Nutrici\u00f3n"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1575092215000765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1575092215000765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T07:41:48Z","timestamp":1717832508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1575092215000765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":121,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1575092215000765"],"URL":"https:\/\/doi.org\/10.1016\/j.endonu.2015.02.006","relation":{},"ISSN":["1575-0922"],"issn-type":[{"value":"1575-0922","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gu\u00eda cl\u00ednica para el manejo de pacientes con carcinoma diferenciado de tiroides de bajo riesgo","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda y Nutrici\u00f3n","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endonu.2015.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 SEEN. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}